Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Hypertension, Portal 2Carcinoma, Hepatocellular 2Motor Activity 1Liver Diseases 1Liver Cirrhosis 1Gastrointestinal Neoplasms 1Breast Neoplasms 1Ascites 1

Interventions

Radiosurgery 24lenvatinib 19Radiofrequency Ablation 16Hepatectomy 13Sorafenib 12Surgical Procedures, Operative 9Radiotherapy 9camrelizumab 7Magnetic Resonance Spectroscopy 7Blood Specimen Collection 7Bevacizumab 7sintilimab 6apatinib 6Immune Checkpoint Inhibitors 6Electroporation 6atezolizumab 5tislelizumab 4Yttrium-90 4Proton Therapy 4Oxaliplatin 4Liver Transplantation 4Doxorubicin 4Control Groups 4Cisplatin 4Chemoembolization, Therapeutic 4Catheter Ablation 4spartalizumab 3entecavir 3X-Rays 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Hepatocellular × Portasystemic Shunt, Transjugular Intrahepatic × Clear all
NCT06622031 2025-01-13

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Sun Yat-sen University

Phase NA Recruiting
42 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04640116 2020-12-19

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Sun Yat-sen University

Phase NA Unknown
30 enrolled
Gastrointestinal

Ascites, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡